Analysis of human brain tissue reveals differences in how immune cells behave in brains with Alzheimer'sdisease compared to healthy brains, indicating a potential new treatment target. University ...
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
"The approach of using benfotiamine in patients with mild Alzheimer's is very promising," said Rajiv Ratan, M.D., Ph.D., Executive Director at Burke Neurological Institute. "This clinical trial builds ...
Some results have been hidden because they may be inaccessible to you